Business Wire

Introducing Starbucks Oleato™ – a Revolutionary New Coffee Ritual

Share

Starbucks today unveiled a transformational innovation in coffee, Oleato – a line of coffee beverages that brings together the unexpected – Starbucks arabica coffee deliciously infused with a spoonful of Partanna cold pressed, extra virgin olive oil. The result is velvety smooth, delicately sweet, and lush coffee that uplifts each cup with an extraordinary new flavor and texture. The new beverage platform which launches in Starbucks stores in Italy on Feb. 22, includes: Oleato™ Caffè Latte, Oleato™ Iced Shaken Espresso, and Oleato™ Golden Foam™ Cold Brew. The Starbucks Reserve Roastery Milan will also debut five beverages to customers on Feb. 22: Oleato™ Caffè Latte, Oleato™ Iced Cortado, Oleato™ Golden Foam™ Cold Brew, Oleato™ Deconstructed, and Oleato™ Golden Foam™ Espresso Martini. Starbucks will begin to introduce the beverages in select markets around the world, starting with Southern California in the United States this spring. Later this year, Japan, the Middle East, and the United Kingdom will launch the beverages.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230221005753/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Introducing Starbucks Oleato™ – a Revolutionary New Coffee Ritual (Photo: Business Wire)

“During my first trip to Milan in 1983, I was captivated by the sense of community, connection, and passion for coffee I found in the city’s espresso bars. It was that trip that inspired me to bring the ritual of handcrafted espresso to Starbucks and to America. Oleato represents the next revolution in coffee that brings together an alchemy of nature’s finest ingredients – Starbucks arabica coffee beans and Partanna cold pressed extra virgin olive oil,” said Howard Schultz, Starbucks interim chief executive officer. “Today I feel just as inspired as I did 40 years ago, Oleato has opened our eyes to fresh new possibilities and a transformational way to enjoy our daily coffee,” said Schultz.

Starbucks continuous search for inspiration revealed a family tradition that has existed in regions of Italy for generations - enjoying a spoonful of extra virgin olive oil each day as an uplifting ritual. This led Starbucks to Partanna, an Italian extra virgin olive oil brand with more than 100 years of tradition and dedication to farming and crafting premium extra virgin olive oil.

Oleato, The New Coffee Ritual

Partanna created a highly curated blend of extra virgin olive oil from the finest Mediterranean olives, including the high-quality Nocellara del Belice (also called Castelvetrano) olives from Partanna, Sicily. The blend was thoughtfully selected to pair perfectly with Starbucks coffee, which is then skillfully infused in the beverage to unlock a smooth and delicious experience like no other.

Starbucks Oleato beverages that will be served in Starbucks stores around the world:

  • Oleato™ Caffè Latte : Starbucks Blonde Espresso Roast, a light roast that is smooth and subtly sweet, is infused with Partanna extra virgin olive oil and steamed with creamy oatmilk to create a velvety smooth, deliciously lush latte.
  • Oleato™ Golden Foam™ Cold Brew : The inviting aroma of lush Partanna extra virgin olive oil infused cold foam cascades slowly through the dark, smooth cold brew, creating a subtle sweetness in the beverage.
  • Oleato™ Iced Shaken Espresso : This coffee-forward beverage offers layers of flavor sweetened with notes of hazelnuts, rich espresso and creamy oatmilk infused with Partanna extra virgin olive oil.

In select markets, customers will also be able to add a press – the equivalent to a spoonful – of Partanna extra virgin olive oil as a customization to select beverages. The press will then be infused (steamed, shaken, or blended) as a customization into select drinks such as espresso beverages and tea lattes. Golden Foam will also be available as a customization, which can be added as a delicious topping on both hot and cold beverages.

Designed to pair perfectly with the exquisite Starbucks Reserve coffee, the Starbucks Reserve Roastery Milan today debuted five Starbucks Reserve Oleato beverages:

  • Oleato™ Caffè Latte : Starbucks Reserve Espresso and creamy oatmilk infused with Partanna extra virgin olive oil create a velvety, luscious latte.
  • Oleato™ Iced Cortado : Starbucks Reserve Espresso, demerara syrup, and a dash of orange bitters and oatmilk is infused with Partanna extra virgin olive oil. It is then served over ice and finished with an orange peel.
  • Oleato™ Golden Foam™ Cold Brew : Starbucks Reserve Cold Brew is lightly sweetened with demerara syrup and finished with Partanna extra virgin olive oil infused cold foam, creating an inviting aroma and subtle sweetness.
  • Oleato™ Deconstructed : An ode to the Italian tradition of combining olive oil with a squeeze of lemon. This beverage pairs Starbucks Reserve Espresso and Partanna extra virgin olive oil infused with a luxurious passionfruit cold foam.
  • Oleato™ Golden Foam™ Espresso Martini : Starbucks Reserve Espresso, vodka and vanilla bean syrup topped with golden foam – a fusion of fior di latte (sweet cream) and Partanna extra virgin olive oil.

“When creating the beverages, we were inspired by the rich history and origin stories of coffee and olive oil – two of nature’s most transcendent ingredients,” said Amy Dilger, principal beverage developer for Starbucks. “Infusing Starbucks coffee with olive oil yielded a velvety smooth, rich texture, with the buttery, round flavors imparted by the olive oil perfectly pairing with the soft, chocolatey notes of the coffee.”

“One thing that’s special about Partanna’s olives is their uniquely nutty, slightly sweet flavors – think of that rich smoothness of a buttery caramel, it’s a natural complement to our coffee,” said Dilger. “Whether you enjoy Oleato hot or cold, you get this really luxurious, textural experience.”

Read more about the inspiration and creation of these beverages here.

Raising the Bar on Coffee Innovation

Italy’s romance with coffee, food and connection has served as an inspiration for the Starbucks Experience since the company’s earliest days, influencing its coffee, food, and store designs, as well as its reverence for artistry.

“The art of coffee craft, curation and creation remains core to Starbucks. Our aspiration to continue to be the world's leader in premium coffee – in both the art and the science – is as strong today as it was more than 50 years ago when Starbucks first opened its doors,” said Schultz. “Embracing our heritage, we remain dedicated to exceeding our customers’ expectations by bringing innovative experiences to savor.”

From the first Starbucks Caffè Latte served in 1984, to Pumpkin Spice Latte, Nitro Cold Brew, and the more recent Iced Shaken Espresso beverages, Starbucks continues to bring its customers innovative beverages at scale.

About Starbucks

Since 1971, Starbucks Coffee Company has been committed to ethically sourcing and roasting high-quality arabica coffee. Today, with nearly 36,000 stores worldwide, the company is the premier roaster and retailer of specialty coffee in the world. Through our unwavering commitment to excellence and our guiding principles, we bring the unique Starbucks Experience to life for every customer through every cup. To share in the experience, please visit us in our stores or online at stories.starbucks.com or starbucks.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Email: press@starbucks.com
Hotline: 206-318-7100

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye